This is a sector ETF that tracks the S&P Health Care Equipment Select Industry Index. It holds US-listed companies in the medical device, health care equipment, and health care supplies sub-industries using a modified equal weighting method, providing diversified exposure with less large-cap concentration.

It suits investors who want to focus on the growth of the medical device and health care equipment industry while avoiding large-cap dominance.

It is a passive (index tracking) ETF managed by State Street.

The fund holds US-listed stocks classified in the health care equipment, medical device, and health care supplies sub-industries, using modified equal weighting. Unlike market-cap weighting, this structure narrows the weight gap between holdings, easing large-cap concentration while giving small and mid-cap stocks meaningful exposure.

• Modified equal weighting eases large-cap concentration
• Broad industry exposure across large, mid, and small caps

Assets under management (AUM) stand at $159.4M, and the total expense ratio is 0.35% per year.

Compared with peer ETFs that offer broad health care exposure, this fund concentrates on the narrow medical device and equipment industry, so its volatility tends to be somewhat higher.

The medical device industry has shown a long-term growth trend, supported by population aging and technological innovation, but it tends to see short-term volatility depending on interest rates, regulation, and earnings seasons. Returns fluctuate with market conditions.

Fund flows follow demand for exposure to specific themes within the health care sector, and because health care is classified as a defensive sector, relative interest sometimes rises during volatile markets.

Its main strength is the diversification that comes from modified equal weighting. Its weaknesses are the volatility that comes with a narrow industry focus and a somewhat higher expense ratio.

The XLV, VHT, FHLC, and IYH shown in the table are broad ETFs that hold the overall health care sector with market-cap weighting, so their exposure differs from XHE, which concentrates narrowly on medical devices. XBI is the biotech version in the same SPDR industry series. A more direct alternative for medical device exposure is IHI, a market-cap-weighted medical device ETF. Investors who want biotech exposure can also consider IBB, and ARKG for a health care innovation theme.

Here are the points to review before investing in XHE. Because it is an ETF concentrated in a single industry, medical devices, checking its volatility, costs, exposure scope, and the characteristics of its equal weighting structure in advance can support your investment decision.

The main risk is volatility from single-industry concentration and a heavy weighting in small and mid-cap stocks. During market corrections, or when health care regulatory issues come to the fore, short-term losses can be larger than those of broad ETFs.

It is a suitable choice for investors who want to concentrate on the medical device and health care equipment industry in a diversified way. For broader health care exposure, XLV or VHT can be alternatives, and for market-cap-weighted medical device exposure, IHI can be an alternative.